Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126662661 | 12666266 | 1 | I | 20160314 | 20160325 | 20160818 | 20160818 | PER | US-JAZZ-2016-US-005802 | JAZZ | 50.45 | YR | F | Y | 0.00000 | 20160818 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126662661 | 12666266 | 1 | PS | XYREM | SODIUM OXYBATE | 1 | Oral | 2.25 G, BID | 21196 | 2.25 | G | ORAL SOLUTION | |||||||
| 126662661 | 12666266 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3.75 G, BID | 21196 | 3.75 | G | ORAL SOLUTION | |||||||
| 126662661 | 12666266 | 3 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | UNKNOWN DOSE | 21196 | ORAL SOLUTION | |||||||||
| 126662661 | 12666266 | 4 | SS | INDAPAMIDE. | INDAPAMIDE | 1 | UNK | 0 | |||||||||||
| 126662661 | 12666266 | 5 | C | MAGNESIUM OXIDE. | MAGNESIUM OXIDE | 1 | U | 0 | |||||||||||
| 126662661 | 12666266 | 6 | C | Probiotic | PROBIOTICS NOS | 1 | U | 0 | |||||||||||
| 126662661 | 12666266 | 7 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 126662661 | 12666266 | 8 | C | DEXTROAMPHETAMINE. | DEXTROAMPHETAMINE | 1 | U | 0 | |||||||||||
| 126662661 | 12666266 | 9 | C | NYSTATIN. | NYSTATIN | 1 | U | 0 | |||||||||||
| 126662661 | 12666266 | 10 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | U | 0 | |||||||||||
| 126662661 | 12666266 | 11 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | U | 0 | |||||||||||
| 126662661 | 12666266 | 12 | C | VITAMIN B6 | PYRIDOXINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 126662661 | 12666266 | 13 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126662661 | 12666266 | 1 | Narcolepsy |
| 126662661 | 12666266 | 4 | Swelling |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126662661 | 12666266 | Dehydration | |
| 126662661 | 12666266 | Headache | |
| 126662661 | 12666266 | Incorrect dose administered | |
| 126662661 | 12666266 | Product label confusion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126662661 | 12666266 | 1 | 201602 | 20160313 | 0 | |
| 126662661 | 12666266 | 2 | 20160314 | 20160319 | 0 | |
| 126662661 | 12666266 | 3 | 201603 | 0 |